Vertex Pharmaceuticals Incorporated shares owned by UBS Group
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $299M | 716k | 418.01 |
| 2023-12-31 | $234M | 575k | 406.89 |
| 2023-09-30 | $173M | 496k | 347.74 |
| 2023-06-30 | $205M | 583k | 351.91 |
| 2023-03-31 | $192M | 610k | 315.07 |
| 2022-12-31 | $176M | 608k | 288.78 |
| 2022-09-30 | $83M | 283k | 292.31 |
| 2022-06-30 | $87M | 309k | 281.79 |
| 2022-03-31 | $124M | 463k | 266.67 |
| 2021-12-31 | $98M | 446k | 219.60 |
| 2021-09-30 | $112M | 618k | 181.39 |
| 2021-06-30 | $114M | 563k | 201.60 |
| 2021-03-31 | $111M | 516k | 214.89 |
| 2020-12-31 | $85M | 359k | 236.35 |
| 2020-09-30 | $56M | 207k | 272.12 |
| 2020-06-30 | $78M | 267k | 290.31 |
| 2020-03-31 | $88M | 369k | 237.95 |
| 2019-12-31 | $66M | 301k | 218.94 |
| 2019-09-30 | $56M | 328k | 169.42 |
| 2019-06-30 | $46M | 252k | 183.38 |
| 2019-03-31 | $46M | 250k | 183.97 |
| 2018-12-31 | $45M | 274k | 165.70 |
| 2018-09-30 | $82M | 426k | 192.73 |
| 2018-06-30 | $61M | 357k | 169.99 |
| 2018-03-31 | $60M | 370k | 163.11 |
| 2017-12-31 | $49M | 326k | 149.79 |
| 2017-09-30 | $37M | 245k | 152.04 |
| 2017-06-30 | $32M | 245k | 128.87 |
| 2017-03-31 | $19M | 173k | 109.35 |
| 2016-12-31 | $18M | 246k | 73.67 |
| 2016-09-30 | $20M | 231k | 87.21 |
| 2016-06-30 | $16M | 186k | 85.94 |
| 2016-03-31 | $17M | 211k | 79.47 |
| 2015-12-31 | $37M | 297k | 125.83 |
| 2015-09-30 | $25M | 235k | 104.13 |
| 2015-03-31 | $34M | 289k | 118.18 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated